Liverpool adult centre

Daniel Palmer is the North West Cancer Research Chair in Medical Oncology at the University of Liverpool. He focuses on hepato-pancreato-biliary (HPB) cancers, developing early-phase trials and translational studies which investigate immune-based therapies, target the tumour microenvironment and develop biomarker-driven approaches for HPB cancer.

Bill Greenhalf is Professor of Molecular Oncology at the University of Liverpool and Director of the Good Clinical Practice Laboratory facility. His research focuses on pancreatic cancer genetics, early detection and translational trials. He holds lead roles in the Liverpool ECMC and the European Registry of Hereditary Pancreatic Diseases, with extensive academic and industry experience.

Charlotte is the Liverpool ECMC operational director. She is an experienced clinical research professional with more than 20 years of expertise in the design, management and delivery of complex clinical trials. She has extensive experience overseeing international multi-centre oncology trials and has played a key role in trial methodology development and process optimisation.

Sara Martin has over 15 years of experience working within oncology research in both the NHS and academic settings. Sara has managed the set-up and delivery of a wide range of research studies, including an international registry, screening studies, biobanking initiatives and phase 1-2 clinical trials.

Carlo Palmieri is a Professor of Translational Oncology and a Consultant Medical Oncologist. He focuses on endocrine breast cancer therapy and leads a portfolio of translational studies and clinical trials in metastatic breast cancer. Carlo has extensive experience in patient and public involvement and engagement, including co-production of research outputs and leading participant-facing events.